Levin, May <br/><br/>
Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine.  [electronic resource] 

 -  Cell death & disease  05 2019 
 - 390 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/s41419-019-1626-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cytarabine--pharmacology<br/>DNA Damage--drug effects<br/>Deoxycytidine Kinase--genetics<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Histones--metabolism<br/>Humans<br/>Hydroxyurea--pharmacology<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Ubiquitination<br/>Zidovudine--pharmacology